Heparin-induced thrombocytopenia: Principles for early recognition and management

Cleveland Clinic Journal of Medicine

Volumn 72, Issue SUPPL.1, 2004, Pages

  Bartholomew, John R ^a   Begelman, Susan M ^a   Almahameed, Amjad ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; DRUG DERIVATIVE; HEPARIN; HIRUDIN DERIVATIVE; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PIPECOLIC ACID DERIVATIVE; RECOMBINANT PROTEIN;

CHEMICALLY INDUCED DISORDER; HUMAN; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME;

ANTICOAGULANTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HIRUDINS; HUMANS; PIPECOLIC ACIDS; PLATELET COUNT; PRACTICE GUIDELINES; RECOMBINANT PROTEINS; RISK ASSESSMENT; THROMBOCYTOPENIA; TIME FACTORS;

EID: 84884549064     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.Suppl_1.S31     Document Type: Article

References (34)

1. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121:535-555.
2. Caiola E. Heparin-induced thrombocytopenia: how to manage it, how to avoid it. Cleve Clin J Med 2000; 67:621-624.
3. Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 1998; 35(Suppl):9-16.
4. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl):311S-337S.
5. Rhodes GR, Dixon RH, Silver D. Heparin-induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg 1977; 186:752-758.
6. Silver D, Kapsch DN, Tsoi EKM. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg 1983; 198:301-306.
7. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344:1286-1292.
8. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135:502-506.
9. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparininduced thrombocytopenia. Ann Intern Med 2002; 136:210-215.
10. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101:502-507.
11. Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood 2003; 101:3049-3051.
12. Warkentin TE, Elavathil LJ, Hayward CPM, et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997; 127:804-812.
13. Srinivasan AF, Rice L, Bartholomew JR, et al. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparininduced thrombocytopenia. Arch Intern Med 2004; 164:66-70.
14. Warkentin TE. Heparin-induced skin lesions. Br J Haematol 1996; 92:494-497.
15. Mims MP, Manian P, Rice L. Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia. Eur J Haematol 2004; 72:366-369.
16. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparininduced thrombocytopenia. Curr Hematology Rep 2003; 2:148-157.
17. Chong BH. Heparin-induced thrombocytopenia. J Thromb Haemost 2003; 1:1471-1478.
18. Eichler P, Raschke R, Lubenow N, et al. The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. Br J Haematol 2002; 116:887-891.
19. Wallis DE, Workman KL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999; 106:629-635.
20. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001; 103:1838-1843.
21. Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999; 99:73-80.
22. Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparininduced thrombocytopenia. Circulation 1999; 100:587-593.
23. Greinacher A, Eichler P, Lubenow N, et al. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 2000; 96:846-851.
24. Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 2004; 164:361-369.
25. Eichler P, Heinz-Juergen F, Lubenow N, et al. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood 2000; 96:2373-2378.
26. Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparininduced thrombocytopenia. Circulation 2003; 108:2062-2065.
27. Lewis BE, Wallis DE, Leya F, et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 2003; 163:1849-1856.
28. Berkowitz SD. Bivalirudin in heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome patients [abstract]. Blood 1999; 94(Suppl 1):101b. Abstract 3617.
29. Campbell KR, Mahaffey KW, Lewis BE, et al. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasive Cardiol 2000; 12(Suppl F):14F-19F.
30. Mahaffey KW, Lewis BE, Wilderman NM, et al. The Anticoagulant Therapy with Bivalirudin to Assist in the performance of percutaneous coronary intervention in patients with heparin-induced Thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol 2003; 15:611-616.
31. Davis Z, Anderson R, Short D, et al. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Ann Thorac Surg 2003; 75:264-265.
32. Merry AF, Raudkivi PJ, Middleton NG. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77:925-931.
33. Chong BH, Gallus AS, Cade JF, et al. Prospective randomized open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study. Thromb Haemost 2001; 86:1170-1175.
34. Eichler P, Kroll H, Greinacher A. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost 2001; 85:950-957.